Most sold healthcare stocks in Q1 2020
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2020, measured as net reductions in reported share positions from Q4 2019 into Q1 2020. Notable reductions at the top of this list include GILEAD SCIENCES INC (GILD), BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), CVS HEALTH CORP (CVS). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | -12,458,968 | -$455.11M | 5 | 3 | 4 | 2 | 13 |
| BMY | BRISTOL-MYERS SQUIBB CO | -11,748,569 | -$1.66B | 5 | 1 | 9 | 5 | 17 |
| SNY | SANOFI-ADR | -10,796,748 | -$854.87M | 0 | 0 | 1 | 1 | 2 |
| CVS | CVS HEALTH CORP | -8,206,809 | -$1.05B | 4 | 7 | 3 | 4 | 16 |
| AVTR | AVANTOR INC | -7,655,382 | -$224.13M | 0 | 1 | 1 | 1 | 2 |
| LLY | ELI LILLY & CO | -7,270,260 | -$943.02M | 3 | 1 | 4 | 0 | 8 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -5,666,486 | -$457.61M | 0 | 1 | 1 | 0 | 2 |
| BAX | BAXTER INTERNATIONAL INC | -5,617,179 | -$500.34M | 2 | 1 | 4 | 0 | 8 |
| PFE | PFIZER INC | -5,454,694 | -$396.86M | 2 | 8 | 5 | 1 | 15 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -4,912,899 | -$218.67M | 0 | 0 | 1 | 0 | 1 |
| MCK | MCKESSON CORP | -3,892,477 | -$554.71M | 2 | 1 | 2 | 3 | 5 |
| COR | CENCORA INC | -3,579,711 | -$300.85M | 1 | 1 | 2 | 1 | 4 |
| ELV | ELEVANCE HEALTH INC | -2,954,856 | -$1.61B | 3 | 4 | 4 | 1 | 13 |
| PRGO | Perrigo Company PLC | -2,321,886 | -$133.15M | 1 | 0 | 2 | 1 | 3 |
| MRNA | MODERNA INC | -2,319,474 | -$34.96M | 1 | 0 | 1 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | -2,182,012 | $15.42M | 0 | 0 | 1 | 1 | 2 |
| IQV | IQVIA HOLDINGS INC | -1,606,063 | -$423.74M | 3 | 0 | 1 | 3 | 4 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,508,179 | -$560.60M | 2 | 1 | 7 | 2 | 12 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -1,301,213 | -$76.80M | 2 | 2 | 2 | 0 | 7 |
| HOLX | HOLOGIC INC | -1,263,954 | -$168.78M | 2 | 1 | 2 | 0 | 5 |
| ZTS | ZOETIS INC | -1,255,533 | -$401.25M | 1 | 1 | 4 | 0 | 7 |
| TDOC | TELADOC HEALTH INC | -1,102,839 | -$77.66M | 1 | 0 | 3 | 0 | 4 |
| BKD | BROOKDALE SENIOR LIVING INC | -1,083,718 | -$63.03M | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -970,071 | -$109.47M | 0 | 0 | 2 | 0 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | -967,759 | -$16.65M | 0 | 1 | 2 | 1 | 3 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -840,734 | -$2.90M | 0 | 0 | 0 | 1 | 0 |
| DXCM | DEXCOM INC | -779,555 | -$121.02M | 2 | 1 | 0 | 1 | 3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -757,858 | -$64.35M | 1 | 1 | 3 | 0 | 5 |
| CAH | CARDINAL HEALTH INC | -718,252 | -$51.28M | 2 | 2 | 2 | 0 | 7 |
| EW | EDWARDS LIFESCIENCES CORP | -695,728 | -$243.75M | 1 | 1 | 7 | 1 | 10 |
| ACAD | ACADIA PHARMACEUTICALS INC | -670,200 | -$28.70M | 0 | 0 | 1 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | -667,700 | -$8.06M | 0 | 0 | 1 | 0 | 1 |
| ILMN | ILLUMINA INC | -559,622 | -$253.72M | 2 | 2 | 0 | 2 | 4 |
| WAT | WATERS CORP | -505,930 | -$368.30M | 1 | 0 | 2 | 0 | 3 |
| ARDX | ARDELYX INC | -475,900 | -$7.19M | 0 | 0 | 1 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | -471,899 | -$19.64M | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -465,422 | -$376.59M | 2 | 4 | 10 | 0 | 19 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -439,089 | -$58.36M | 1 | 0 | 1 | 0 | 2 |
| LGND | LIGAND PHARMACEUTICALS | -421,245 | -$62.87M | 0 | 0 | 1 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | -420,956 | -$49.51M | 1 | 0 | 2 | 0 | 3 |
| DVA | DAVITA INC | -413,686 | $9.30M | 1 | 1 | 3 | 0 | 5 |
| MD | PEDIATRIX MEDICAL GROUP INC | -412,959 | -$19.29M | 1 | 0 | 1 | 0 | 2 |
| OSUR | ORASURE TECHNOLOGIES INC | -387,003 | $7.27M | 0 | 0 | 1 | 0 | 1 |
| MNKD | MANNKIND CORP | -364,075 | -$470.00K | 0 | 0 | 0 | 1 | 0 |
| SAVA | CASSAVA SCIENCES INC | -362,000 | -$2.60M | 0 | 0 | 1 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -331,974 | -$426.46M | 0 | 4 | 5 | 0 | 10 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -310,153 | -$499.00K | 0 | 0 | 1 | 1 | 1 |
| PINC | PREMIER INC-CLASS A | -272,663 | -$29.27M | 0 | 0 | 2 | 0 | 2 |
| OPK | OPKO HEALTH INC | -262,415 | -$400.00K | 0 | 0 | 1 | 1 | 1 |
| HAE | HAEMONETICS CORP/MASS | -255,431 | -$62.64M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q1 2020
What are the most sold Healthcare stocks in Q1 2020?
The most sold healthcare stocks in Q1 2020 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2020?
Among filers in this sector, net reductions were largest in companies such as GILEAD SCIENCES INC (GILD), BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2019).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.